Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21757
Abstract: Heparin‐induced thrombocytopenia (HIT) can occur following exposure to heparin and is characterized by thrombocytopenia with increased risk for thrombosis. This condition is mediated by formation of immunoglobulin G antibodies against platelet factor 4/heparin complexes that… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24884
Abstract: Heparin‐induced thrombocytopenia (HIT) is a severe complication of heparin therapy associated with thrombosis that requires a quick diagnosis. Therefore, laboratory assays must provide an accurate and swift answer. This work aims to evaluate the performances… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26811
Abstract: Heparin‐induced thrombocytopenia and thrombosis (HITT) may result in microsurgical flap failure. This study investigated the outcomes of HITT in primary lymphedema patients who underwent vascularized lymph node transplantations (VLNT). read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Methods in molecular biology"
DOI: 10.1007/978-1-4939-7196-1_19
Abstract: Heparin-induced thrombocytopenia (HIT) represents a significant high morbidity complication of heparin therapy. The clinicopathological diagnosis of HIT remains challenging for many reasons; thus, laboratory testing represents an important component of an accurate diagnosis. Although there… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Annals of Hematology"
DOI: 10.1007/s00277-019-03851-3
Abstract: Dear Editor, Heparin-induced thrombocytopenia (HIT) is a clinical syndrome caused by the formation of antibodies against the platelet factor 4 (PF4)-heparin complex associated with heparin therapy [1]. Antibody binding results in platelet activation and elaboration… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-017-1566-1
Abstract: Arterial and venous complications are major causes of morbidity and mortality in myeloproliferative neoplasms (MPNs). MPNs patients, frequently receive heparin. Heparin-induced thrombocytopenia (HIT) is a rare but potentially life-threatening complication resulting in a severe acquired… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-020-02320-3
Abstract: Heparin-induced thrombocytopenia (HIT) is a highly thrombogenic condition. Cancer patients are already at high risk of thrombosis. The treatment and outcomes of HIT in cancer patients are not well established. We retrospectively identified patients with… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-021-02711-9
Abstract: After the wide use of linezolid (LZD), numerous reports of uncontrolled studies have suggested that LZD is associated with high rates of thrombocytopenia. We conducted this matched case–control study to identify the risk factors for… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Annals of Medicine and Surgery"
DOI: 10.1016/j.amsu.2021.103070
Abstract: Introduction Heparin-induced thrombocytopenia is a rare complication of heparin therapy associated with thrombocytopenia and mainly thrombotic complications. Case report we herein describe a case of a woman hospitalized for management of a severe case of… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Annals of vascular surgery"
DOI: 10.1016/j.avsg.2019.12.017
Abstract: Heparin-bonded expanded polytetrafluoroethylene (ePTFE) grafts are increasingly used for dialysis access in lieu of standard ePTFE grafts to improve patency. Despite no established association between heparin-bonded graft placement and formation of platelet antibodies, cases of… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Chest"
DOI: 10.1016/j.chest.2021.07.066
Abstract: TOPIC: Allergy and Airway TYPE: Medical Student/Resident Case Reports INTRODUCTION: Idiopathic thrombocytopenic purpura (ITP) is an acquired bleeding disorder, characterized by thrombocytopenia due to autoantibodies against platelet antigens. The pathogenesis is not clearly understood;however, it… read more here.